Andrea Marranci
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.
Journal: Cell death discovery
Published: November 26, 2025
Correction: The landscape of BRAF transcript and protein variants in human cancer.
Journal: Molecular cancer
Published: February 03, 2025
PARP1 in melanoma: Mechanistic insights and implications for basic and clinical research.
Journal: Cancer letters
Published: November 25, 2024
Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.
Journal: Journal of translational medicine
Published: July 09, 2024
Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status.
Journal: International journal of molecular sciences
Published: May 15, 2023
PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation.
Journal: Journal of hematology & oncology
Published: December 23, 2022
Resistance to Arsenite and Arsenate in Saccharomyces cerevisiae Arises through the Subtelomeric Expansion of a Cluster of Yeast Genes.
Journal: International journal of environmental research and public health
Published: May 30, 2022
p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
Journal: The Journal of biological chemistry
Published: February 14, 2022
High-Throughput Identification of miRNA-Target Interactions in Melanoma Using miR-CATCHv2.0.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2021
A eutherian-specific microRNA controls the translation of Satb2 in a model of cortical differentiation.
Journal: Stem cell reports
Published: October 26, 2020
Last Updated: 09/26/2026